摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Hydroxy-1,7-naphthyridin | 67967-09-3

中文名称
——
中文别名
——
英文名称
3-Hydroxy-1,7-naphthyridin
英文别名
3-Hydroxy-1,7-naphthyridine;1,7-naphthyridin-3-ol
3-Hydroxy-1,7-naphthyridin化学式
CAS
67967-09-3
化学式
C8H6N2O
mdl
MFCD11521578
分子量
146.148
InChiKey
WYLVDQCBKZPULR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    46
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    3-氯-1,7-萘啶 生成 3-Hydroxy-1,7-naphthyridin
    参考文献:
    名称:
    PLAS H. C. VAN DER; WOZNIAK M.; VELDHUIZEN A. VAN, REC. TRAV. CHIM. , 1976, 95, NO 10, 233-236
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • [EN] PYRIDAZINONE DERIVATIVES AND USE THEREOF AS P2X7 RECEPTOR INHIBITORS<br/>[FR] DÉRIVÉS DE PYRIDAZINONE ET LEUR UTILISATION COMME INHIBITEURS DU RÉCEPTEUR P2X7
    申请人:NISSAN CHEMICAL IND LTD
    公开号:WO2009057827A1
    公开(公告)日:2009-05-07
    Novel pyridazinone compounds of formula (I), which inhibit the purinergic P2X7 receptor and are useful for prevention, therapy and improvement of inflammatory and immunological diseases.
    翻译结果为:新型的哒嗪酮化合物,其化学公式为(I),能够抑制嘌呤能P2X7受体,并对预防、治疗和改善炎症性和免疫性疾病有益。
  • [EN] 3-ALKYLIDENEHYDRAZINO SUBSTITUTED HETEROARYL COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS<br/>[FR] UTILISATION DE COMPOSES HETEROARYLES A SUBSTITUTION 3-ALKYLIDENEHYDRAZINO EN TANT QU'ACTIVATEURS DU RECEPTEUR DE LA THROMBOPOIETINE
    申请人:NISSAN CHEMICAL IND LTD
    公开号:WO2004108683A1
    公开(公告)日:2004-12-16
    A compound represented by the formula (1): wherein A is a nitrogen atom or CR4, B is an oxygen atom, a sulfur atom or NR9 (provided that when A is a nitrogen atom, B is not NH), R1 is a C2-14; aryl group, L1 is a bond, CR10R11, an oxygen atom, a sulfur atom or NR12, X is OR13, SR13 or NR14NR15, R2 is a hydrogen atom, a formyl group, a C1-10; alkyl group or the like, L2 is a bond or the like, L3 is a bond, CR17R18, an oxygen atom, a sulfur atom or NR19, L4 is a bond, CR20R21, an oxygen atom, a sulfur atom or NR22, Y is an oxygen atom, a sulfur atom or NR23, and R3 is a C2-14; aryl group, a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.
    化合物的结构式(1)如下:其中A是氮原子或CR4,B是氧原子、硫原子或NR9(但当A是氮原子时,B不是NH),R1是C2-14芳基,L1是键,CR10R11、氧原子、硫原子或NR12,X是OR13、SR13或NR14NR15,R2是氢原子、甲酰基、C1-10烷基或类似物,L2是键或类似物,L3是键,CR17R18、氧原子、硫原子或NR19,L4是键,CR20R21、氧原子、硫原子或NR22,Y是氧原子、硫原子或NR23,R3是C2-14芳基、化合物的互变异构体、前药或药学上可接受的盐或其溶剂化合物。
  • ALPHA-SUBSTITUTED VINYLTIN COMPOUND
    申请人:Tatsuta Kuniaki
    公开号:US20090023939A1
    公开(公告)日:2009-01-22
    To provide α-substituted vinyltin useful for the search for function-developing substances such as pharmaceuticals/agrichemicals and functional materials and for the construction of a compound library. An α-substituted vinyltin compound represented by the formula (1), a tautomer or salt of the compound or a solvate thereof: R 2 CH═C(R 3 )Sn(R 1 ) 3 (1) wherein R 1 is a C 1-10 alkyl group, a C 2-14 aryl group or the like, R 2 is a C 2-14 aryl group, a C 2-9 heterocyclyl group, a C 3-10 cycloalkyl group or the like, and R 3 is a carbamoyl group, a thiocarbamoyl group, an isocyanate group, an isothiocyanate group, a formylamino group, a thioformylamino group, an isonitrile group, an urea group, a carbamate group or the like.
    提供α-取代的乙烯基锡,用于寻找功能发展物质,如药物/农药和功能材料,以及用于构建化合物库。由下式表示的α-取代的乙烯基锡化合物(1)或其互变异构体或盐或溶剂合物:R2CH═C(R3)Sn(R1)3(1)其中R1是C1-10烷基,C2-14芳基或类似物,R2是C2-14芳基,C2-9杂环基,C3-10环烷基或类似物,R3是氨基甲酰基,硫氨基甲酰基,异氰酸酯基,异硫氰酸酯基,甲酰氨基基,硫代甲酰氨基基,异腈基,脲基,氨基甲酸酯基或类似物。
  • OPTICALLY ACTIVE DINICKEL COMPLEX AND METHOD FOR PRODUCING OPTICALLY ACTIVE AMINE USING THE OPTICALLY ACTIVE DINICKEL COMPLEX AS CATALYST
    申请人:Shibasaki Masakatsu
    公开号:US20100298559A1
    公开(公告)日:2010-11-25
    There is provided a novel optically active dinickel complex and/or a production method of an optically active amine by an asymmetric Mannich reaction using the dinickel complex as a catalyst. An optically active dinickel complex of Formula (I) or Formula (I′): [where R 0 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 are each independently a hydrogen atom, a halogen atom, a C 1-10 alkyl group or a C 1-10 alkoxy group, etc., R 2 and R 3 together form, together with a benzene ring bonded to them, a naphthalene ring, etc. A novel production method of an optically active amine by an asymmetric Mannich reaction using the dinickel complex as a catalyst.
    提供了一种新型光学活性二镍配合物和/或使用该二镍配合物作为催化剂进行不对称Mannich反应制备光学活性胺的生产方法。公式(I)或公式(I′)的光学活性二镍配合物:[其中R0、R1、R2、R3、R4、R5、R6和R7分别独立地是氢原子、卤素原子、C1-10烷基或C1-10烷氧基等,R2和R3连同与它们结合的苯环形成萘环等。使用该二镍配合物作为催化剂,通过不对称Mannich反应制备光学活性胺的新型生产方法。
  • HYDRAZIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR
    申请人:Miyaji Katsuaki
    公开号:US20090253751A1
    公开(公告)日:2009-10-08
    Compounds effective for preventing, treatment or improving diseases against which activation of the thrombopoietin receptor is effective are provided. A compound represented by the formula (I) (wherein R 1 , R 2 , R 3 , L 1 , L 2 , X and Y are defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.
    提供了一种用于预防、治疗或改善激活血小板生成素受体有效对抗的疾病的化合物。该化合物由式(I)所表示(其中R1、R2、R3、L1、L2、X和Y在描述中被定义),该化合物的互变异构体、前药或药物可接受的盐或其溶剂化物。
查看更多